Irritant contact dermatitis following extracorporeal shockwave therapy: a case report.


Journal

Annals of palliative medicine
ISSN: 2224-5839
Titre abrégé: Ann Palliat Med
Pays: China
ID NLM: 101585484

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 27 04 2020
accepted: 18 11 2020
pubmed: 8 2 2021
medline: 13 7 2021
entrez: 7 2 2021
Statut: ppublish

Résumé

Extracorporeal shockwave therapy (ESWT) has been widely used in the treatment of various musculoskeletal disorders with remarkable efficacy, with no relevant severe complications being reported. In this study, we report a rare case of acute irritant contact dermatitis following ESWT with serious skin damage, which has never been previously reported. A 42-year-old male patient with osteonecrosis of the femoral head (ONFH) was subjected to two sessions of ESWT. In the first session of low-energy ESWT (0.15 mJ/mm2, 3 Hz, and a total of 2,000 impulses), no local or systematic adverse reactions occurred. Three months later, he was subjected to a second session of high-energy ESWT (0.28 mJ/mm2, 4 Hz, and a total of 2,000 impulses). However, on the second day, the patient presented with itching and painful erythema and blisters on the local skin of the hip. Based on these manifestations and the results of patch testing, the patient was diagnosed with irritant contact dermatitis and treated by an oral antihistamine combined with external calamine lotions. The skin lesions began to develop exudate from erosion and scabs had gradually formed with treatment, and finally dry scabs fell off with no scar left. This is the first reported irritant contact dermatitis after ESWT. Although bone pathologies should be treated with high energy, patients should be informed of this potential rare complication.

Identifiants

pubmed: 33548985
doi: 10.21037/apm-20-1830
pii: apm-20-1830
doi:

Substances chimiques

Irritants 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7083-7087

Auteurs

Lijun Shi (L)

Graduate School of Peking Union Medical College, Chin-Japan Friendship institute of Clinical Medicine, Beijing, China.

Zhizhuo Li (Z)

Department of Orthopedics, Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China.

Peixu Wang (P)

Graduate School of Peking Union Medical College, Chin-Japan Friendship institute of Clinical Medicine, Beijing, China.

Meng Fan (M)

Center for Osteonecrosis and Joint Preserving & Reconstruction, Department of Orthopaedic Surgery, China-Japan Friendship Hospital, Beijing, China.

Wei Sun (W)

Graduate School of Peking Union Medical College, Chin-Japan Friendship institute of Clinical Medicine, Beijing, China; Center for Osteonecrosis and Joint Preserving & Reconstruction, Department of Orthopaedic Surgery, China-Japan Friendship Hospital, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH